ORYZON Presents vafidemstat 12-month Clinical Data From its Phase IIa Clinical Trials ETHERAL and REIMAGINE-AD in Alzheimer’s at the Virtual AD/PD-2021 Conference
ETHERAL:º Primary endpoint met: treatment with vafidemstat for 12 months was safe and well tolerated in…
DeepKeep Launches First-Of-its-Kind Vibe AI Red Teaming Capability for AI Security
From the Heart: Discover Taiwan’s 19 Hot Spring Regions and Embark on Asia’s Most Restorative Mountain and Coastal Spa Journey
Lithosphere Reduces Blockchain Fragmentation Through MultX Interoperability Engine
Solutionz Group Announces Launch of Growth Multiplier Category Framework and Establishment of G-Squared Consortia